CoChat

Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression

Open access

The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.

Abstract

Intravenous ketamine is posited to rapidly reverse depression by rapidly enhancing neuroplasticity. In human patients, we quantified gray matter microstructural changes on a rapid (24-h) timescale within key regions where neuroplasticity enhancements post-ketamine have been implicated in animal models. In this study, 98 unipolar depressed adults who failed at least one antidepressant medication were randomized 2:1 to a single infusion of intravenous ketamine (0.5 mg/kg) or vehicle (saline) and completed diffusion tensor imaging (DTI) assessments at pre-infusion baseline and 24-h post-infusion. DTI mean diffusivity (DTI-MD), a putative marker of microstructural neuroplasticity in gray matter, was calculated for 7 regions of interest (left and right BA10, amygdala, and hippocampus; and ventral Anterior Cingulate Cortex) and compared to clinical response measured with the Montgomery-Asberg Depression Rating Scale (MADRS) and the Quick Inventory of Depressive Symptoms-Self-Report (QIDS-SR). Individual differences in DTI-MD change (greater decrease from baseline to 24-h post-infusion, indicative of more neuroplasticity enhancement) were associated with larger improvements in depression scores across several regions. In the left BA10 and left amygdala, these relationships were driven primarily by the ketamine group (group * DTI-MD interaction effects: p = 0.016–0.082). In the right BA10, these associations generalized to both infusion arms ( p = 0.007). In the left and right hippocampus, on the MADRS only, interaction effects were observed in the opposite direction, such that DTI-MD change was inversely associated with depression change in the ketamine arm specifically (group * DTI-MD interaction effects: p = 0.032–0.06). The acute effects of ketamine on depression may be mediated, in part, by acute changes in neuroplasticity quantifiable with DTI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-023-02451-0

Cites

64 of 64 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Associations between change in depression and change in mean diffusivity as a function of treatment. Within-group correlations between change in QIDS-SR (A, C, E) or MADRS (B, D, F) scores and the change in mean diffusivity for select brain regions. Post hoc Pearson r and p values shown separately for the vehicle (n = 31) and ketamine (n = 67) groups; see main text and Table 2 for full omnibus regression statistics. A positive change in depression score indicates an improvement in depression on that scale, and a positive change in MD indicates decreased diffusion in that region (interpreted as increased plasticity).
Fig. 1 Associations between change in depression and change in mean diffusivity as a function of treatment. Within-group correlations between change in QIDS-SR (A, C, E) or MADRS (B, D, F) scores and the change in mean diffusivity for select brain regions. Post hoc Pearson r and p values shown separately for the vehicle (n = 31) and ketamine (n = 67) groups; see main text and Table 2 for full omnibus regression statistics. A positive change in depression score indicates an improvement in depression on that scale, and a positive change in MD indicates decreased diffusion in that region (interpreted as increased plasticity).CC BY · PubMed Central
Fig. 2 Associations between change in depression and change in hippocampal mean diffusivity as a function of treatment. Within-group correlations between change in MADRS score and the change in mean diffusivity for left (A) and right (B) hippocampus. Post hoc Pearson r and p values shown separately for the vehicle (n = 31) and ketamine (n = 67) groups; see main text and Table 2 for full omnibus regression statistics. A positive change in depression score indicates an improvement in depression on the MADRS, and a positive change in MD indicates decreased diffusion in that region (interpreted as increased plasticity).
Fig. 2 Associations between change in depression and change in hippocampal mean diffusivity as a function of treatment. Within-group correlations between change in MADRS score and the change in mean diffusivity for left (A) and right (B) hippocampus. Post hoc Pearson r and p values shown separately for the vehicle (n = 31) and ketamine (n = 67) groups; see main text and Table 2 for full omnibus regression statistics. A positive change in depression score indicates an improvement in depression on the MADRS, and a positive change in MD indicates decreased diffusion in that region (interpreted as increased plasticity).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 64 references

Cited by

See all 79

Metadata

Authors
Kopelman, J., Keller, T. A., Panny, B., Griffo, A., Degutis, M., Spotts, C., Cruz, N., Bell, E., Do-Nguyen, K., Wallace, M. L., Mathew, S. J., Howland, R. H., & Price, R. B.
Affiliations
  • University of California San Diego (US)
  • Carnegie Mellon University (US)
  • University of Pittsburgh (US)
  • Michael E. DeBakey VA Medical Center (US)
Corresponding author
Price, Rebecca B.
Venue
Translational Psychiatry
Published
2023-05-09
Volume
13
Issue
1
Pages
159-159
ISSN
2158-3188 (ISSN-L)
OpenAlex
W4376132496
Cited by
60
References
64
Citations by year
2026: 15 · 2025: 20 · 2024: 21 · 2023: 4
FWCI
9.31
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH113857)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
  • Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
Keywords
intravenous ketamine, treatment-resistant depression, neuroplasticity, gray matter microstructure, mean diffusivity, diffusion tensor imaging, rapid-acting antidepressants, anterior cingulate cortex, amygdala, hippocampus, individual differences in treatment response
MeSH terms
Adult, Animals, Cerebral Cortex, Depression, Humans, Ketamine, Neuronal Plasticity, Diffusion Tensor Imaging

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression. https://app.cochat.ai/papers/10.1038/s41398-023-02451-0
The paper
Kopelman, J., Keller, T. A., Panny, B., Griffo, A., Degutis, M., Spotts, C., Cruz, N., Bell, E., Do-Nguyen, K., Wallace, M. L., Mathew, S. J., Howland, R. H., & Price, R. B. (2023). Rapid neuroplasticity changes and response to intravenous ketamine: a randomized controlled trial in treatment-resistant depression. Translational Psychiatry. https://doi.org/10.1038/s41398-023-02451-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.